The ACR BI-RADS (Breast Imaging Reporting and Data System) 5th Edition is the standard framework for mammography breast imaging assessment. Enter mass, calcification, architectural distortion, and asymmetry findings — plus modality — and the calculator assigns a BI-RADS category from 0–6 with subcategories 4A, 4B, and 4C, returning malignancy probability and biopsy / follow-up / routine screening management. Pair with TI-RADS (thyroid) and PI-RADS (prostate) for other RADS systems.

Imaging Findings

Shape
Margin
Density / Echogenicity
Morphology
Distribution

Assessment Result

Select findings on the left to generate a suggested BI-RADS category and management recommendation.

⚕️ Clinical Limitations: This tool applies ACR BI-RADS 5th Edition criteria to suggest a category and is for educational use only — not a diagnostic decision tool. Category assignment in practice requires full imaging correlation, prior studies, and clinical context. A BI-RADS 3 finding in a patient with BRCA1/2 mutation may warrant biopsy despite the <2% guideline probability. Always apply clinical judgment.

Learn more about interpreting calculator results → How to Use Medical Calculators

BI-RADS Categories Quick Reference

ACR BI-RADS 5th Edition assigns one of seven assessment categories — including three subcategories of category 4 — based on the most suspicious finding entered. The recommended management action and approximate malignancy probability follow:

Category Assessment Malignancy Probability Management
0 Incomplete Additional imaging needed
1 Negative ~0% Routine screening
2 Benign Finding 0% Routine screening
3 Probably Benign <2% 6-month short-interval follow-up
4A Low Suspicion 2–10% Core needle biopsy
4B Moderate Suspicion 10–50% Core needle biopsy
4C High Suspicion 50–95% Core needle biopsy (urgent)
5 Highly Suggestive ≥95% Biopsy + surgical consult

Mass Lesions

A mass in BI-RADS is a space-occupying lesion seen in two projections. Three features determine the mass-level assessment:

A mass with only some features entered defaults to BI-RADS 0 (incomplete) until full characterization is available.

Calcifications

Calcifications are tiny calcium deposits seen on mammography. BI-RADS classification depends on morphology (what they look like) and distribution (where they appear):

Architectural Distortion

Architectural distortion is a mammographic finding where the normal breast parenchyma is distorted without a visible central mass — often with radiating lines or retraction. New architectural distortion is BI-RADS 4B minimum; biopsy is required unless the finding can be confidently attributed to a prior biopsy site or surgical scar (in which case it can be downgraded).

Asymmetry

Asymmetry refers to an area of fibroglandular tissue seen on one breast that lacks a corresponding matching area on the other. BI-RADS 5th Edition recognizes four asymmetry patterns:

How to Use This Calculator

The BI-RADS calculator follows the ACR 5th Edition two-step approach. First, enter the imaging modality (mammography, ultrasound, or MRI — the calculator applies the same logic; terminology varies by modality). Second, enter each finding present: mass characteristics, calcification morphology and distribution, the presence of architectural distortion, and the asymmetry pattern. The calculator returns the BI-RADS category assigned by the most suspicious finding:

  1. Modality — Mammography is the default; ultrasound and MRI use modified lexicons but the same category definitions.
  2. Mass — Toggle Yes and select shape, margin, and density. Spiculated margin alone qualifies as BI-RADS 5.
  3. Calcifications — Toggle Yes and select morphology (benign vs. suspicious) and distribution.
  4. Architectural Distortion — Toggle Yes if present (BI-RADS 4B minimum).
  5. Asymmetry — Pick one of the four asymmetry patterns or None.

The calculator takes the highest-suspicion finding across all entered items and maps it to a BI-RADS category. Multiple findings present simultaneously: only the most suspicious is reported.

Modality-Specific Notes

BI-RADS 3 Follow-up Protocol

BI-RADS 3 (probably benign) has a defined short-interval follow-up schema before downgrade to BI-RADS 2:

If the finding enlarges or develops suspicious features at any follow-up, upgrade to BI-RADS 4 and recommend biopsy. BI-RADS 3 is not appropriate for symptomatic findings (palpable lump, bloody nipple discharge) or new lesions in known cancer patients; BRCA carriers often warrant biopsy even at BI-RADS 3.

Limitations

Clinical sources & references

Peer-reviewed sources backing the formulas and thresholds used on this page. Click any citation to open the original paper.

  1. American College of Radiology. ACR BI-RADS Atlas: Breast Imaging Reporting and Data System. 5th ed. Reston, VA: ACR; 2013.
  2. Lehman CD, et al. MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer. N Engl J Med. 2007;356(13):1295–1303.
  3. Kerlikowske K, Creasman J. Breast Cancer Surveillance Consortium: screening outcomes. JAMA Intern Med. 2015;175(4):648–649.